Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

1(50.0%)

Phase 3

1(50.0%)

2Total

N/A(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT05982145Completed

The Use of Compression in Institutions and at People's Homes

Role: collaborator

NCT01615692Withdrawn

The 36-month Extension to Follow up Sub Study

Role: collaborator

NCT01793194Not ApplicableCompleted

Preventing the Development of Venous Insufficiency in Pregnant Women Through Use of Compression Stockings

Role: collaborator

NCT00143598Phase 3Completed

The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome

Role: collaborator

NCT01615705Completed

Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) Trial

Role: collaborator

All 5 trials loaded